Abstract
The availability of p53 knockout mice generated by gene targeting has enabled us to investigate the functional role of the p53 tumor suppressor gene in initiation, promotion, and progression of carcinogenesis in vivo, using mouse skin as a model system. The number, size, and growth rate of benign papillomas were not increased in the p53 heterozygous mice in comparison with wild type. The p53 null mice showed a reduced yield of papillomas, but these underwent much more rapid malignant progression, with some poorly differentiated carcinomas developing after only 10 weeks of promotion. Progression rate was also greater in heterozygous than in wild-type mice and was associated with loss of the remaining wild-type allele. Most tumors from all groups had activating mutations in the H-ras gene. Absence of p53, therefore, does not augment the frequency of initiation or the rate of promotion but greatly enhances malignant progression.
Keywords
BiologyCarcinogenesisCancer researchWild typeTumor initiationTumor suppressor geneKnockout mouseSuppressorTumor progressionNull alleleGeneTumor promotionGene knockoutAlleleIn vivoRatónMutantSkin tumorGene targetingImmunologyGenetics
MeSH Terms
910-Dimethyl-12-benzanthraceneAnimalsBlottingSouthernCarcinomaDNAGenesp53GenesrasGenotypeHeterozygoteHumansMaleMiceMiceInbred StrainsPapillomaSkin NeoplasmsTetradecanoylphorbol Acetate
Affiliated Institutions
Related Publications
<b>A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53‐null mammary epithelial cell mode</b> .
ABSTRACT Approximately 40% of human breast cancers contain alterations in the tumor suppressor p53. The p53 172R‐H gain‐of‐function mutant (equivalent to the common 175R‐H human...
Conformation-dependent phosphorylation of p53
Phosphorylation of the p53 tumor suppressor protein is known to modulate its functions. Using bacterially produced glutathione S -transferase (GST)-p53 fusion protein and baculo...
Genetic alterations in breast cancer
Abstract The etiology of breast cancer involves a complex interplay of various factors, including genetic alterations. Many studies have been devoted to the identification and c...
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Silencing of the BRCA1 gene by promoter hypermethylation occurs in primary breast and ovarian carcinomas, especially in the presence of LOH and in specific histopathologic subgr...
Prospective identification of tumorigenic breast cancer cells
Breast cancer is the most common malignancy in United States women, accounting for >40,000 deaths each year. These breast tumors are comprised of phenotypically diverse popul...
Publication Info
- Year
- 1993
- Type
- article
- Volume
- 74
- Issue
- 5
- Pages
- 813-822
- Citations
- 457
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
457
OpenAlex
11
Influential
361
CrossRef
Cite This
Christopher J. Kemp,
Lawrence A. Donehower,
Allan Bradley
et al.
(1993).
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.
Cell
, 74
(5)
, 813-822.
https://doi.org/10.1016/0092-8674(93)90461-x
Identifiers
- DOI
- 10.1016/0092-8674(93)90461-x
- PMID
- 8374952